NDC 55910-931

Daytime Nighttime Severe Cold and Flu Relief

Acetaminophen Dextromethorphan Hbr Guaifenesin Phenylephrine Hci Doxylaminesucinate

Daytime Nighttime Severe Cold and Flu Relief is a Kit in the Human Otc Drug category. It is labeled and distributed by Dolgencorp, Inc. (dollar General & Rexall). The primary component is .

Product ID55910-931_486ce42f-7906-4b33-961e-f08818c207f7
NDC55910-931
Product TypeHuman Otc Drug
Proprietary NameDaytime Nighttime Severe Cold and Flu Relief
Generic NameAcetaminophen Dextromethorphan Hbr Guaifenesin Phenylephrine Hci Doxylaminesucinate
Dosage FormKit
Marketing Start Date2018-03-31
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart341
Labeler NameDolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 55910-931-16

1 KIT in 1 KIT (55910-931-16) * 237 mL in 1 BOTTLE * 237 mL in 1 BOTTLE
Marketing Start Date2018-03-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55910-931-16 [55910093116]

Daytime Nighttime Severe Cold and Flu Relief KIT
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart341
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-03-31

Drug Details

OpenFDA Data

SPL SET ID:fb3809b1-4b10-4027-9cae-d97f121410cf
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 1369842
  • 1431245
  • 1860085
  • UPC Code
  • 0349580753167
  • NDC Crossover Matching brand name "Daytime Nighttime Severe Cold and Flu Relief" or generic name "Acetaminophen Dextromethorphan Hbr Guaifenesin Phenylephrine Hci Doxylaminesucinate"

    NDCBrand NameGeneric Name
    11822-0328daytime nighttime severe cold and flu reliefAcetaminophen, dextromethorphan HBr, Doxylamine Succinate, Guaifenesin, Phenylephrine HCl
    49580-0813Daytime Nighttime Severe Cold and Flu ReliefAcetaminophen Dextromethorphan HBr Guaifenesin Phenylephrine HCI DoxylamineSucinate
    55910-931Daytime Nighttime Severe Cold and Flu ReliefAcetaminophen Dextromethorphan HBr Guaifenesin Phenylephrine HCI DoxylamineSucinate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.